Govt to allow parallel submission of marketing, manufacturing approvals

Published On 2022-06-02 12:45 GMT   |   Update On 2022-06-03 06:12 GMT
Advertisement

Through a recent Gazette Notification, the Ministry of Health and Family Welfare (MoHFW) has issued a draft of certain rule to amend the Drug Rules 1945 allowing parallel submission of application for grant of renewal of manufacturing and sales license serum, hormones, vaccines ,toxins, anti-toxins and other biological and special products, applications for grant of manufacturing permission for new drugs under the New Drugs and Clinical Trials Rules, 2019 and application for approval to manufacture new drug under rule 122B of the Drugs Rules.

Advertisement

For more details, check out the full story on the link below:             

Govt To Allow Parallel Submission Of Marketing And Manufacturing Approvals


Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News